Last Modified: October 2, 2003
Conference Dates: October 29, 2003
Conference Location: Penn Tower Bridge Level Conference Room
Sponsoring Group: Abramson Cancer Center and Leukemia-Lymphoma Society
Topics Covered: "Latest Developments in Research and Clinical Applications" "The Use of Radioimmunotherapy" "Living Well and Coping with Lymphoma"
Conference Objectives: Patient Education
Who Should Attend: Patients, friends and family members
Registration Information: Jill Harrington LaMorie, MSW, LSW Patient Services Coordinator 215-349-8869
Conference Fees: Free/Parking Paid
Continuing Education: No
Aug 3, 2011 - Bortezomib, given in combination with rituximab, cyclophosphamide, vincristine, and prednisone, is feasible for treating patients with advanced-stage follicular lymphoma, and the combination of bortezomib, bendamustine, and rituximab is active in patients with follicular lymphoma who have received previous treatment, according to two studies published online Aug. 1 in the Journal of Clinical Oncology.
Apr 5, 2012
Jan 25, 2015